User menu

Additional Analysis of the Secondary End Point of Biochemical Recurrence Rate in a Phase 3 Trial (CS21) Comparing Degarelix 80 mg Versus Leuprolide in Prostate Cancer Patients Segmented by Baseline Characteristics

Bibliographic reference Tombal, Bertrand ; Miller, Kurt ; Boccon-Gibod, Laurent ; Schroeder, Fritz ; Shore, Neal ; et. al. Additional Analysis of the Secondary End Point of Biochemical Recurrence Rate in a Phase 3 Trial (CS21) Comparing Degarelix 80 mg Versus Leuprolide in Prostate Cancer Patients Segmented by Baseline Characteristics. In: European Urology, Vol. 57, no. 5, p. 836-42 (2010)
Permanent URL http://hdl.handle.net/2078.1/34051